Clofarabine

Clofarabine is an anti-cancer medication used to treat acute lymphoblastic leukemia (ALL) in children who are 2 years of age and older. It is a type of chemotherapy drug and works by stopping the growth of cancer cells. Clofarabine is given as an injection into a vein (IV) and is usually given over 1-5 days. Common side effects include fever, nausea, fatigue, and low white blood cell count.

Clofarabine is a prescription medication used to treat a specific type of cancer in children and young adults. Here's a detailed description of its properties:

Function:

  • Classified as a purine nucleoside antimetabolite, a type of chemotherapy medication.
  • Works by interfering with the growth and division of cancer cells, ultimately leading to their death.

Applications:

  • Specifically approved for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL) in children and young adults aged 1 to 21 years. This refers to a type of blood cancer that has either returned after initial treatment (relapsed) or has not responded adequately to previous treatments (refractory).

Dosage and Administration:

  • Typically administered as an intravenous (IV) infusion over 2 hours daily for 5 consecutive days.
  • The exact dosage is determined by a doctor based on various factors like the patient's age, weight, and overall health.

Important Notes:

  • Clofarabine has significant side effects, which can be severe, and requires close monitoring by a healthcare professional during treatment. Some common side effects include:
    • Low blood cell counts (which can increase the risk of infections, bleeding, and fatigue)
    • Nausea and vomiting
    • Liver problems
    • Fever
    • Hair loss
    • Mouth sores
  • Not recommended for pregnant or breastfeeding women due to potential harm to the developing fetus or infant.
  • Only available through certified healthcare institutions and should be administered by trained professionals.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01B - Antimetabolites
L01BB Purine analogues
External Links